 <h1>Iopidine Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>apraclonidine ophthalmic</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about apraclonidine ophthalmic. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Iopidine.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to apraclonidine ophthalmic: ophthalmic solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, apraclonidine ophthalmic (the active ingredient contained in Iopidine) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking apraclonidine ophthalmic:</p><p>
<i>For 0.5% apraclonidine</i>
</p><p>
<i>More common</i>
</p><ul>
<li>Allergic reaction (redness, itching, tearing of the eye)</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision or change in vision</li>
<li>chest pain</li>
<li>clumsiness or unsteadiness</li>
<li>depression</li>
<li>dizziness</li>
<li>eye discharge, irritation, or pain</li>
<li>irregular heartbeat</li>
<li>numbness or tingling in the fingers or toes</li>
<li>raising of the upper eyelid</li>
<li>rash around the eyes</li>
<li>redness of the eyelid or inner lining of the eyelid</li>
<li>swelling of the eye, eyelid, or inner lining of the eyelid</li>
<li>swelling of the face, hands, or feet</li>
</ul><p>
<i>For 1% apraclonidine</i>
</p><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision</li>
<li>diarrhea</li>
<li>dry mouth</li>
<li>eye redness</li>
<li>fainting</li>
<li>feeling cold or sleepy</li>
<li>irregular heartbeat</li>
<li>lightheadedness</li>
<li>redness, swelling, or whitening of the eyelids</li>
<li>slow heartbeat</li>
<li>stomach pain</li>
<li>stuff or runny nose</li>
<li>swelling of the eyelid</li>
<li>trouble sleeping</li>
<li>unusual dreams</li>
<li>unusual taste in the mouth</li>
<li>vomiting</li>
<li>watering of eye</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking apraclonidine ophthalmic:</i>
</p><p>
<i>For 1% apraclonidine</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Confusion</li>
<li>clumsiness</li>
<li>drowsiness</li>
<li>low body temperature</li>
<li>muscle aches</li>
<li>muscle weakness</li>
<li>shivering</li>
<li>sleepiness</li>
<li>slow heartbeat</li>
<li>tiredness</li>
<li>weak or feeble pulse</li>
<li>weight gain</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of apraclonidine ophthalmic may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>For 0.5% apraclonidine</i>
</p><p>
<i>More common</i>
</p><ul>
<li>Dryness of the mouth</li>
<li>eye discomfort</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Change in taste or smell</li>
<li>constipation</li>
<li>crusting or scales on the eyelid or corner of the eye</li>
<li>discoloration of white part of the eye</li>
<li>drowsiness or sleepiness</li>
<li>dry nose or eyes</li>
<li>general feeling of discomfort or illness</li>
<li>headache</li>
<li>increased sensitivity of the eyes to light</li>
<li>muscle aches</li>
<li>nausea</li>
<li>nervousness</li>
<li>paleness of the eye or inner lining of the eyelid</li>
<li>runny nose</li>
<li>sore throat</li>
<li>tiredness or weakness</li>
<li>trouble in sleeping</li>
</ul><p>
<i>For 1% apraclonidine</i>
</p><p>
<i>More common</i>
</p><ul>
<li>Increase in size of the pupil of the eye</li>
<li>paleness of the eye or inner lining of the eyelid</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Runny nose</li>
</ul><p>
<!-- end ophthalmic solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to apraclonidine ophthalmic: ophthalmic solution</i></p><h3>General</h3><p>The most commonly reported side effects were hyperemia, pruritus, discomfort, and tearing.<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Conjunctivitis (up to 23%), eye pruritus (up to 23%), ocular hyperemia/hyperemia (up to 23%), increased lacrimation/tearing (up to 15%), lid edema/eyelid edema (up to 15%), ocular discomfort/discomfort (up to 15%), ocular pruritus/pruritus (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Blurred vision, conjunctival blanching, conjunctival follicles, dimmed vision, dry eye, eye disorder, eyelid margin crusting, eyelid/lid retraction, mydriasis, ocular blanching, ocular discharge, ocular inflammation</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal vision, blepharitis, blepharoconjunctivitis, conjunctival edema, conjunctival hemorrhage, corneal erosion, corneal infiltrates, corneal staining, eye discharge, eye edema, eye inflammation, eye irritation, eye pain, eyelid/lid disorder/upper lid elevation, eyelid/lid erythema, eyelid/lid scales, hypotony of eye, keratitis, keratopathy, photophobia, punctate keratitis, visual acuity reduced, visual impairment</p>
<p><b>Frequency not reported</b>: Conjunctival microhemorrhage<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dry mouth (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Constipation, nausea</p>
<p><b>Uncommon</b> (0.1% to 1%): Abdominal pain, diarrhea, stomach discomfort, throat irritation, vomiting</p>
<p><b>Frequency not reported</b>: Emesis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Abnormal sensation in eye/foreign body sensation (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Ocular injection</p>
<p><b>Uncommon</b> (0.1% to 1%): Edema, irritation, pain</p>
<p><b>Frequency not reported</b>: Burning, hypotony, itching<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Asthma, dyspnea, nasal decongestion, nasal dryness/dry nose, parosmia, pharyngitis, rhinitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Rhinorrhea</p>
<p><b>Rare</b> (0.01% to 0.1%): Increased upper airway secretion, nasal discomfort</p>
<p><b>Frequency not reported</b>: Increased pharyngeal secretion, nasal burning, shortness of breath<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Abnormal coordination, dizziness, dysgeusia, headache, paresthesia, somnolence, taste perversion</p>
<p><b>Uncommon</b> (0.1% to 1%): Abnormal dreams, blepharospasm, eyelid ptosis, postural dizziness, vasovagal syncope</p>
<p><b>Rare</b> (0.01% to 0.1%): Hypoesthesia</p>
<p><b>Frequency not reported</b>: Dream disturbances, extremity numbness, taste abnormality, vasovagal attack</p>
<p><b>Postmarketing reports</b>: Syncope<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Bradycardia was reported in neonates and infants given after a single dose of the 1% ophthalmic solution.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Arrythmia, chest pain, irregular heart rate, peripheral edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Bradycardia, conjunctival vascular disorders, orthostatic hypotension, palpitations, vasodilation</p>
<p><b>Frequency not reported</b>: Chest burning, chest heaviness, hypertension, hypotension, orthostatic episode<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Contact dermatitis, dermatitis, facial/face edema</p>
<p><b>Rare</b> (0.01% to 0.1%): Hyperhidrosis, pruritus</p>
<p><b>Frequency not reported</b>: Clammy palms, pruritus not associated with rash, sweaty palms<sup>[Ref]</sup></p><h3>Other</h3><p>Lethargy was reported in neonates and infants given after a single dose of the 1% ophthalmic solution.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Asthenia, fatigue, malaise</p>
<p><b>Rare</b> (0.01% to 0.1%): Feeling cold and hot, feeling hot</p>
<p><b>Frequency not reported</b>: Body heat sensation, head cold sensation, lethargy<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression, insomnia, nervousness</p>
<p><b>Uncommon</b> (0.1% to 1%): Irritability<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia</p>
<p><b>Rare</b> (0.01% to 0.1%): Extremity pain<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Eye allergy<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Decreased libido<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Allergic response, hypersensitivity<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Decreased oxygen saturation<sup>[Ref]</sup></p><p>Decreased oxygen saturation was reported in neonates and infants given after a single dose of the 1% ophthalmic solution.<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Iopidine (apraclonidine)." Alcon Laboratories Inc, Fort Worth, TX. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Iopidine (apraclonidine ophthalmic)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Generic Availability</li>
<li>Drug class: ophthalmic glaucoma agents</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Iopidine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Glaucoma</li>
<li>Postoperative Increased Intraocular Pressure</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to apraclonidine ophthalmic: ophthalmic solution</i></p><h3>General</h3><p>The most commonly reported side effects were hyperemia, pruritus, discomfort, and tearing.<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Conjunctivitis (up to 23%), eye pruritus (up to 23%), ocular hyperemia/hyperemia (up to 23%), increased lacrimation/tearing (up to 15%), lid edema/eyelid edema (up to 15%), ocular discomfort/discomfort (up to 15%), ocular pruritus/pruritus (up to 15%)</p><p><b>Common</b> (1% to 10%): Blurred vision, conjunctival blanching, conjunctival follicles, dimmed vision, dry eye, eye disorder, eyelid margin crusting, eyelid/lid retraction, mydriasis, ocular blanching, ocular discharge, ocular inflammation</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal vision, blepharitis, blepharoconjunctivitis, conjunctival edema, conjunctival hemorrhage, corneal erosion, corneal infiltrates, corneal staining, eye discharge, eye edema, eye inflammation, eye irritation, eye pain, eyelid/lid disorder/upper lid elevation, eyelid/lid erythema, eyelid/lid scales, hypotony of eye, keratitis, keratopathy, photophobia, punctate keratitis, visual acuity reduced, visual impairment</p><p><b>Frequency not reported</b>: Conjunctival microhemorrhage<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dry mouth (up to 15%)</p><p><b>Common</b> (1% to 10%): Constipation, nausea</p><p><b>Uncommon</b> (0.1% to 1%): Abdominal pain, diarrhea, stomach discomfort, throat irritation, vomiting</p><p><b>Frequency not reported</b>: Emesis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Abnormal sensation in eye/foreign body sensation (up to 15%)</p><p><b>Common</b> (1% to 10%): Ocular injection</p><p><b>Uncommon</b> (0.1% to 1%): Edema, irritation, pain</p><p><b>Frequency not reported</b>: Burning, hypotony, itching<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Asthma, dyspnea, nasal decongestion, nasal dryness/dry nose, parosmia, pharyngitis, rhinitis</p><p><b>Uncommon</b> (0.1% to 1%): Rhinorrhea</p><p><b>Rare</b> (0.01% to 0.1%): Increased upper airway secretion, nasal discomfort</p><p><b>Frequency not reported</b>: Increased pharyngeal secretion, nasal burning, shortness of breath<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Abnormal coordination, dizziness, dysgeusia, headache, paresthesia, somnolence, taste perversion</p><p><b>Uncommon</b> (0.1% to 1%): Abnormal dreams, blepharospasm, eyelid ptosis, postural dizziness, vasovagal syncope</p><p><b>Rare</b> (0.01% to 0.1%): Hypoesthesia</p><p><b>Frequency not reported</b>: Dream disturbances, extremity numbness, taste abnormality, vasovagal attack</p><p><b>Postmarketing reports</b>: Syncope<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Bradycardia was reported in neonates and infants given after a single dose of the 1% ophthalmic solution.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Arrythmia, chest pain, irregular heart rate, peripheral edema</p><p><b>Uncommon</b> (0.1% to 1%): Bradycardia, conjunctival vascular disorders, orthostatic hypotension, palpitations, vasodilation</p><p><b>Frequency not reported</b>: Chest burning, chest heaviness, hypertension, hypotension, orthostatic episode<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Contact dermatitis, dermatitis, facial/face edema</p><p><b>Rare</b> (0.01% to 0.1%): Hyperhidrosis, pruritus</p><p><b>Frequency not reported</b>: Clammy palms, pruritus not associated with rash, sweaty palms<sup>[Ref]</sup></p><h3>Other</h3><p>Lethargy was reported in neonates and infants given after a single dose of the 1% ophthalmic solution.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Asthenia, fatigue, malaise</p><p><b>Rare</b> (0.01% to 0.1%): Feeling cold and hot, feeling hot</p><p><b>Frequency not reported</b>: Body heat sensation, head cold sensation, lethargy<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression, insomnia, nervousness</p><p><b>Uncommon</b> (0.1% to 1%): Irritability<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Myalgia</p><p><b>Rare</b> (0.01% to 0.1%): Extremity pain<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Eye allergy<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Decreased libido<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Allergic response, hypersensitivity<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Decreased oxygen saturation<sup>[Ref]</sup></p><p>Decreased oxygen saturation was reported in neonates and infants given after a single dose of the 1% ophthalmic solution.<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_3">3. "Product Information. Iopidine (apraclonidine)." Alcon Laboratories Inc, Fort Worth, TX. </p><h2>More about Iopidine (apraclonidine ophthalmic)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Generic Availability</li>
<li>Drug class: ophthalmic glaucoma agents</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Iopidine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Glaucoma</li>
<li>Postoperative Increased Intraocular Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>